PI
ARLZ

Putnam Investments’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Putnam Investments’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-122,766
Closed -$263K – 1421
2017
Q1 		$263K Sell
122,766
-108,415
-47% -$407K ﹤0.01% 1186
2016
Q4 		$1.02M Sell
231,181
-2,312
-1% -$11K ﹤0.01% 1006
2016
Q3 		$1.13M Sell
233,493
-375,592
-62% -$1.71M ﹤0.01% 994
2016
Q2 		$2.01M Buy
609,085
+136,320
+29% +$514K ﹤0.01% 927
2016
Q1 		$1.68M Buy
+472,765
New +$2.44M ﹤0.01% 991

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

Putnam Investments's ARLZ Position: Q2 2017 in Review

Putnam Investments sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2017, closing a stake of 122,766 shares — an estimated $263K sold.

Putnam Investments first reported a position in ARLZ in Q1 2016 and held it in 5 quarters. The position peaked at $2.01M in Q2 2016. 72 funds tracked by Wall St. Rank hold ARLZ as of Q2 2017.

  • Putnam Investments reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 122,766 Aralez Pharmaceuticals Inc. shares in Q2 2017, an estimated $263K.
  • Putnam Investments first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 5 quarters.
  • Putnam Investments's Aralez Pharmaceuticals Inc. position peaked at $2.01M in Q2 2016.
  • 72 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.